Results of Telescoping Nail In OI; a Case Series

August 28, 2021 updated by: Nariman Abol Oyoun, MD, Assiut University

Results of Telescoping Nail in. OI; A Case Series

Assess the postoperative functional outcomes after surgical correction of skeletal deformities of lower limbs in osteogenesis imperfecta patients as regard ambulation status, postoperative complications and reoperation rate.

Study Overview

Status

Recruiting

Detailed Description

Osteogenesis imperfecta (OI) is a rare heterogeneous group of inherited disorders characterized by brittle bones, frequent fractures, and skeletal deformities that affect an individual's ability to walk. Based on Sillence classification, there are four types of OI; Type I (mild, non-deforming), Type II (perinatal lethal), Type III (severely deforming), and Type IV (moderately deforming). Recently 3 types added type V, VI and type VII.

Deformities of the long bones are common in patients with osteogenesis imperfecta particularly in the lower limbs Where they are also more severe. Multiple fractures can occur and the ability to walk may be compromised.

The goal of orthopaedic surgery implies the correction of long bone bowing, rotational malalignment, angular deformity and prevention or reduction of the fracture incidence .Surgical intervention in the form of multiple osteotomies, realignment and fixation by intramedullary rods can correct deformity of the long bones and provides internal support enhancing the potential for standing and assisted or independent walking Sofield and Millar, Page and Mead popularized the operation of multiple osteotomies and fixation by intramedullary rods. In 1963 the baily dubow nail was first introduced The telescopic rodding and nailing have been developed in order to obtain a long lasting osteosynthesis in a growing long bone, thus, reducing the need of replacement. The evolution of telescoping rods for the treatment of fractures and deformity in children with diminished bone Quality has resulted in an approved and commercially available new single entry telescopic rod system, the Fassier Duval Telescopic IM System (FD-rod).

In recent publications a high reoperation rate for proximal rod migration and a complication rate up to 40% because of rod migration, limited telescoping and joint protrusion was found.

We hope that our study will advance the proper surgical intervention for children with osteogenesis imperfecta for better functional outcomes

Study Type

Observational

Enrollment (Anticipated)

22

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Assiut, Egypt, 71526
        • Recruiting
        • Assiut University Hospital AUH
        • Contact:
          • Assiut University Hospital AUH
          • Phone Number: 0020882333327
          • Email: med@aun.edu.eg
        • Contact:
          • Assiut University Hospital AUH

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 years to 11 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

all Osteogenesis imperfecta patients admitted at assiut university pediatric and main hospitals with age range 3- 11 years old presented with lower limb skeletal deformities with or without fracture will be included in our study

Description

Inclusion Criteria:

  • Age from 3-11 years
  • Severe lower limb deformity presented with or without fracture

Exclusion Criteria:

  • Nondisplaced/incomplete fractures in minimally deformed bones
  • Deformity angulation less than 20 degree

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ambulation status
Time Frame: All patients will be assessed clinically and radiologically for deformity 6 months after surgery.
the mobility status of each child will be allocated to one of the scores of the Gillette Functional Assessment Questionnaire Ambulation Scale and Hoffer and Bollock score
All patients will be assessed clinically and radiologically for deformity 6 months after surgery.
Rod Complications
Time Frame: All patients will be assessed radiologically for evidence of rod complications within the first two years after surgery.
Radiographic evidence of rod problems including migration, bending, breakage, disengagement, jamming (failure of expansion/telescoping)
All patients will be assessed radiologically for evidence of rod complications within the first two years after surgery.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bone consolidation
Time Frame: All patients will be assessed clinically and radiologically one month after surgery.
patients will be assessed for the average time in weeks of consolidation at the osteotomy site(s)
All patients will be assessed clinically and radiologically one month after surgery.
Timing of weight-bearing
Time Frame: All patients will be assessed clinically within the first three months after surgery.
The average time in weeks until full weight bearing
All patients will be assessed clinically within the first three months after surgery.
Refracture
Time Frame: All patients will be assessed clinically and radiologically for refracture within the first two years after surgery.
The occurrence of a second fracture at the same long bone with the rod in place or in association with any rod complication
All patients will be assessed clinically and radiologically for refracture within the first two years after surgery.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee Range of Motion
Time Frame: All patients will be assessed clinically for knee range of motion 6 months after surgery.
The range within which the knee on the operated side can move in degrees
All patients will be assessed clinically for knee range of motion 6 months after surgery.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nariman Abol Oyoun, MD, Lecturer, Assiut University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2020

Primary Completion (Anticipated)

December 1, 2023

Study Completion (Anticipated)

March 1, 2024

Study Registration Dates

First Submitted

December 13, 2020

First Submitted That Met QC Criteria

January 1, 2021

First Posted (Actual)

January 5, 2021

Study Record Updates

Last Update Posted (Actual)

September 2, 2021

Last Update Submitted That Met QC Criteria

August 28, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteogenesis Imperfecta

Clinical Trials on telescoping intramedullary nail

3
Subscribe